REGISTERED NUMBER: 04690909 (England and Wales)

OPIDIS LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

Page

Balance Sheet

1

to

2

CURRENT ASSETS

34,642

48,061

PREPAYMENTS AND ACCRUED INCOME

200

112

CREDITORS

Amounts falling due within one year

(1,074

)

(16,325

)

NET CURRENT ASSETS

33,768

31,848

TOTAL ASSETS LESS CURRENT LIABILITIES

33,768

31,848

ACCRUALS AND DEFERRED INCOME

(492

)

(918

)

NET ASSETS

33,276

30,930

CAPITAL AND RESERVES

33,276

30,930

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Opidis Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

04690909

Registered office:

123 Higher Lane

Langland

SWANSEA

SA3 4PS

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was NIL (2023 - NIL).

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 29 September 2025 and were signed by:

Dr A J Townsend - Director